Viracta Therapeutics (VIRX) Stock Chart & Stock Price History $0.02 +0.00 (+10.00%) As of 02:31 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viracta Therapeutics Stock Price Performance The Viracta Therapeutics (VIRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 96.97%, with a year-to-date return of -88.38%. In the past month, the stock has increased 10.00%, reflecting recent market activity. As of the latest close, Viracta Therapeutics traded at $0.02 with a market cap of $676 thousand and volume of 244,556 shares. Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.00%1 Month Performance+10.00%3 Month Performance-43.16%Year-To-Date Performance-88.38%1 Year Performance-96.97% VIRX Stock Chart for Wednesday, June, 11, 2025 VIRX Chart by TradingView Viracta Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$0.02$0.02+10.00%$0.02$0.0252,268 shs$743,000.0006/10/2025$0.02$0.02+9.68%$0.02$0.02244,556 shs$676,000.0006/09/2025$0.02$0.02-8.82%$0.02$0.0281,439 shs$676,000.0006/06/2025$0.02$0.02$0.02$0.0244,350 shs$676,000.0006/05/2025$0.02$0.02+3.66%$0.02$0.02149,334 shs$676,000.0006/04/2025$0.02$0.02+6.49%$0.02$0.0238,381 shs$652,000.0006/03/2025$0.02$0.02$0.02$0.0270,305 shs$612,000.0006/02/2025$0.02$0.02-15.85%$0.02$0.02148,654 shs$612,000.0005/30/2025$0.02$0.02+2.23%$0.02$0.02198,834 shs$727,000.0005/29/2025$0.02$0.02$0.02$0.02397,216 shs$711,000.00 Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$0.02$0.02$0.02$0.0210,485 shs$711,000.0005/27/2025$0.02$0.02$0.02$0.0243,558 shs$711,000.0005/26/2025$0.02$0.02$0.02$0.0280,763 shs$711,000.0005/23/2025$0.02$0.02+3.47%$0.02$0.0280,763 shs$711,000.0005/22/2025$0.02$0.02-6.49%$0.02$0.0210,409 shs$688,000.0005/21/2025$0.02$0.02+8.82%$0.02$0.0210,543 shs$735,000.0005/20/2025$0.02$0.02$0.02$0.0212,606 shs$676,000.0005/19/2025$0.02$0.02$0.02$0.0284,738 shs$676,000.0005/16/2025$0.02$0.02-2.86%$0.02$0.022,634 shs$676,000.0005/15/2025$0.02$0.02+2.94%$0.02$0.0242,221 shs$696,000.0005/14/2025$0.02$0.02-3.41%$0.02$0.02196,649 shs$676,000.0005/13/2025$0.02$0.02-7.37%$0.02$0.02146,423 shs$699,000.0005/12/2025$0.02$0.02+11.76%$0.02$0.0230,522 shs$755,000.00 Related Companies PTN Stock Price Chart AWH Stock Price Chart TNFA Stock Price Chart GLMD Stock Price Chart PTIX Stock Price Chart ENTO Stock Price Chart APVO Stock Price Chart GRTX Stock Price Chart SHPH Stock Price Chart VCNX Stock Price Chart Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIRX Stock Free VIRX Stock Alerts